Eoin P. Flanagan

Jun 2, 2024 | neurologylive.com | Eoin P. Flanagan

WATCH TIME: 4 minutes"One thing we were highlighting is that in MOGAD, it doesn't tend to form scars, and the lesions often resolve, which is very different from MS."Myelin oligodendrocyte glycoprotein (MOG)-associated disease (MOGAD) is a rare antibody-mediated inflammatory demyelinating disorder of the central nervous system.

Apr 30, 2024 | neurologylive.com | Eoin P. Flanagan

April 30, 2024The professor of neurology at Mayo Clinic discussed the importance of standardizing MOG- antibody testing techniques and the need for effective treatments in patients living with MOGAD.

Apr 29, 2024 | neurologylive.com | Eoin P. Flanagan

April 29, 2024The professor of neurology at Mayo Clinic talked about MOG-antibody associated disease, a relatively newly recognized demyelinating condition of the central nervous system.

Mar 7, 2024 | journals.sagepub.com | Eoin P. Flanagan

Get full access to this articleView all access and purchase options for this article. Data availability statementData sharing not applicable to this article as no data sets were generated or analyzed during this study. References1. Toledano M. Infectious myelopathies. Continuum 2021; 27: 93–120. 2. Jeantin L, Leclercq D, Tran S, et al. Longitudinally extensive posterolateral myelitis revealing invasive CNS aspergillosis in an immunocompetent patient. Mult Scler 2024. [Online ahead of print]3. Miceli MH.

Dec 26, 2023 | jamanetwork.com | Adrian Budhram |Sarosh R Irani |Eoin P. Flanagan

Looking Beyond Syndrome-Based Criteria for Autoimmune Encephalitis—The Need for Complementary Neural Antibody–Based Diagnostic Criteria Encephalitis classically presents as a syndrome of rapidly progressive encephalopathy with memory deficits, altered mental status, and/or psychiatric symptoms.1 Syndrome-based criteria for autoimmune encephalitis (AE) were proposed as part of a diagnostic algorithm and help clinicians navigate differential diagnoses while awaiting antibody results.1 With use...